MZD-27197-82391 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-20
Dose 1 — Pfizer-BioNTech
2021-09-10
Dose 2 — Pfizer-BioNTech
2021-11-16
Registered in v-safe
2021-11-16
Dose 3 — Pfizer-BioNTech
2021-11-16
Health check-in — day 0, dose 3
Feeling: Good · None

Adult check-in
2021-11-17
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Site: Pain · Fatigue or tiredness

Adult check-in
2021-11-18
Survey response — days 1–6 daily, dose 3
MedDRA: Back pain, Lymphadenopathy — Feeling: Fair · Site: Pain, Swelling · Muscle or body aches, Fatigue or tiredness, Abdominal pain

Free text: the swelling was in my lymph nosed in my arm pit and my mid to lower back was sore and ached

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-20	Pfizer-BioNTech	No
2	2021-09-10	Pfizer-BioNTech	No
3	2021-11-16	Pfizer-BioNTech	No

Free text

Release 10 — days 1–6 daily, dose 3

2021-11-18

Systemic reaction (other): the swelling was in my lymph nosed in my arm pit and my mid to lower back was sore and ached

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Back pain	·	·	✓
SRO	Lymphadenopathy	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release